This is a phase I study to assess the safety and tolerability of an oral preparation that may help patients with chronic hepatitis B in the future.
|Study number||5489 - RECRUITMENT CURRENTLY ON HOLD|
|Group||People with chronic hepatitis B virus infection|
|Gender||Male / Female|
|Age||18 - 65|
|Compensation||Reimbursement between £525 and £225 depending on participation. Reimbursement for out-of-pocket expenses such as travel, parking or meals with valid receipts|
|Recruiting from||Apr 2018|
|Additional details||BMI must be between 18-32kg/m2. Involvement will be approximately 16 weeks.|